| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,166 |
5,674 |
$283K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,192 |
3,855 |
$198K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,035 |
2,660 |
$138K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
722 |
652 |
$41K |
| 80053 |
Comprehensive metabolic panel |
3,009 |
2,624 |
$27K |
| 87428 |
|
779 |
697 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,661 |
4,082 |
$23K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
783 |
692 |
$16K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
686 |
590 |
$12K |
| 81001 |
|
2,966 |
2,679 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,005 |
790 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
339 |
296 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
553 |
270 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
658 |
565 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
662 |
582 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
133 |
119 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
245 |
174 |
$4K |
| 84484 |
|
477 |
366 |
$4K |
| 81025 |
|
430 |
371 |
$4K |
| 80076 |
|
311 |
276 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
5,677 |
4,895 |
$2K |
| 83690 |
|
342 |
292 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
133 |
132 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
63 |
60 |
$1K |
| 87070 |
|
121 |
120 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
83 |
65 |
$905.33 |
| 83735 |
|
132 |
116 |
$849.75 |
| 85610 |
|
156 |
138 |
$688.55 |
| 82550 |
|
94 |
78 |
$612.76 |
| 85730 |
|
123 |
107 |
$578.30 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
50 |
47 |
$525.62 |
| 83880 |
|
33 |
27 |
$513.72 |
| 84443 |
Thyroid stimulating hormone (TSH) |
35 |
29 |
$462.55 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
31 |
24 |
$420.64 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14 |
12 |
$311.45 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
18 |
17 |
$252.66 |
| 87420 |
|
14 |
13 |
$153.21 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
133 |
120 |
$121.19 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
161 |
141 |
$120.15 |
| 85027 |
|
23 |
16 |
$94.64 |
| 83605 |
|
18 |
12 |
$85.31 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
51 |
46 |
$62.60 |
| 85007 |
|
37 |
29 |
$23.29 |
| 81003 |
|
14 |
13 |
$17.61 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
925 |
812 |
$12.72 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
102 |
97 |
$4.42 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
16 |
14 |
$0.26 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
76 |
63 |
$0.00 |